Sensitive detection of integrated and free transcripts in chimeric antigen receptor T-cell manufactured cell products using droplet digital polymerase chain reaction

• Published in: Cytotherapy (Oxford, England) Vol. 23; no. 5; pp. 452 - 458
• Main Authors: Wiltshire, Timothy D., Milosevic, Dragana, Jacob, Eapen K., Grebe, Stefan K., Dietz, Allan B.
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01-05-2021
• Subjects: CAR-T; ddPCR; release testing; replication-competent lentivirus (RCL); VSV-G; ddPCR; VSV-G; release testing; CAR-T; replication-competent lentivirus (RCL)
• ISSN: 1465-3249; 1477-2566
• DOI: 10.1016/j.jcyt.2020.12.012

Viral vectors are commonly used to introduce chimeric antigen receptor (CAR) constructs into cell therapy products for the treatment of human disease. They are efficient at gene delivery and integrate into the host genome for subsequent replication but also carry risks if replication-competent lentivirus (RCL) remains in the final product. An optimal CAR T-cell product should contain sufficient integrated viral material and no RCL. Current product testing methods include cell-based assays with slow turnaround times and rapid quantitative polymerase chain reaction (PCR)-based assays that suffer from high result variability. The authors describe the development of a droplet digital PCR (ddPCR) method for detection of the vesicular stomatitis virus G glycoprotein envelope sequence, required for viral assembly, and the replication response element to measure integration of the CAR construct.
Assay validation included precision, linearity, sensitivity, specificity and reproducibility over a range of low to high concentrations.
The limit of detection was 10 copies/μL, whereas negative samples showed <1.3 copies/μL. Within and between assay imprecision coefficients of variation across the reportable range (10–10 000 copies/μL) were <25%. Accuracy and linearity were verified by comparing known copy numbers with measured copy numbers (R2 >0.9985, slope ~0.9). Finally, serial measurements demonstrated very good long-term reproducibility (>95% of replicate results within the originally established ± two standard deviations).
DDPCR has excellent reproducibility, linearity, specificity and sensitivity for detecting RCL and assuring the safety of patient products in a rapid manner. The technique can also likely be adapted for the rapid detection of other targets during cell product manufacturing, including purity, potency and sterility assays.